Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial

Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial

Abstract Background The use of cardiovascular medication for the primary prevention of cardiovascular disease (CVD) is potentially inappropriate when potential risks outweigh the potential benefits. It is unknown whether deprescribing preventive cardiovascular medication in patients without a strict...

Full description

Bibliographic Details
Main Authors: Clare H. Luymes, Rosalinde K. E. Poortvliet, Nan van Geloven, Margot W. M. de Waal, Yvonne M. Drewes, Jeanet W. Blom, Nynke Smidt, Willem J. J. Assendelft, Wilbert B. van den Hout, Wouter de Ruijter, Mattijs E. Numans
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Medicine
Subjects:
General practice
Preventive medicine
Cardiovascular disease
Antihypertensive agent
Anticholesteremic agent
Inappropriate prescribing
Online Access:http://link.springer.com/article/10.1186/s12916-017-0988-0

Internet

http://link.springer.com/article/10.1186/s12916-017-0988-0

Similar Items